Differences between familial and sporadic cases of vitiligo

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 7, 2012, Pages 915-918

  Karelson, M ^a   Silm, H ^a   Salum, T ^b   Koks S ^a   Kingo, K ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIADRENAL CORTEX ANTIBODY; ANTIBODY; ANTINUCLEAR ANTIBODY; PARIETAL CELL ANTIBODY; RHEUMATOID FACTOR; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BODY SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPIGMENTATION; DISEASE SEVERITY; FAMILIAL DISEASE; FAMILIAL VITILIGO; FEMALE; HAIR DISEASE; HUMAN; LEUKOTRICHIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SPORADIC VITILIGO; VITILIGO;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; HUMANS; MIDDLE AGED; VITILIGO; YOUNG ADULT;

EID: 84862752957     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04131.x     Document Type: Article

References (14)

1. Lu T, Gao T, Wang A, et al. Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol 2007; 46: 47-51. (Pubitemid 46029724)
2. Handa S, Kaur I,. Vitiligo: clinical findings in 1436 patients. J Am Acad Dermatol 1999; 26: 653-657. (Pubitemid 29510347)
3. Nordlund JJ, Majumder PP,. Recent investigations on vitiligo vulgaris. Dermatol Clin 1997; 15: 69-78. (Pubitemid 27034656)
4. Martis J, Bhat R, Nandakishore B, et al. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol 2002; 68: 92-93. (Pubitemid 44057988)
5. Misri R, Khopkar U, Shankarkumar U, et al. Comparative case control study of clinical features and human leukocyte antigen susceptibility between familial and nonfamilial vitiligo. Indian J Dermatol Venereol Leprol 2009; 75: 583-587.
6. Alzolibani A,. Genetic epidemiology and heritability of vitiligo in the Qassim region of Saudi Arabia. Acta dermatoven APA 2009; 18: 119-124.
7. Ando I, Chi HI, Nakagawa H, et al. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 1993; 129: 408-410. (Pubitemid 23308244)
8. Laberge G, Mailloux CM, Gowan K, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005; 18: 300-305. (Pubitemid 41032889)
9. Dogra S, Parsad D, Handa S, et al. Late onset vitiligo: a study of 182 patients. Int J Dermatol 2005; 44: 193-196. (Pubitemid 40425661)
10. Liu JB, Li M, Yang S, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 2005; 30: 327-331. (Pubitemid 40835320)
11. Boisseau-Garsaud AM, Saint-Cyr I, Quist D, et al. Familial aggregation of vitiligo in the French West Indies (Isle of Martinique). Eur J Dermatol 2001; 11: 554-556. (Pubitemid 33044455)
12. Klisnick A, Schmidt J, Dupond JL, et al. Vitiligo in multiple autoimmune syndrome: a retrospective study of 11 cases and review of the literature. Rev Med Interne 1998; 19: 348-352. (Pubitemid 28239837)
13. Amerio P, Di Rollo D, Carbone A, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol 2010; 20: 354-358.
14. Daneshpazhooh M, Mostofizadeh G, Behjati J, et al. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatology 2006; 6: 3.